Clinical Trials Directory

Trials / Completed

CompletedNCT04215081

ExoAtlet II For SCI Patients

ExoAtlet II Lower Extremity Exoskeleton Safety and Efficacy Use With Spinal Cord Injured Individuals

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
COSMO ROBOTICS CO., Ltd · Industry
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This study will evaluate the ExoAtlet II exoskeleton for safety and effectiveness of providing persons with a spinal cord injury (SCI) who are non-ambulatory or have limited ambulatory function, to stand up and ambulate under a variety of conditions.

Detailed description

The study will introduce the ExoAtlet II exoskeleton to SCI patients with lower extremity paralysis (partial or complete) and provide rehabilitative standing and walking intervention. The study will be conducted with a trained clinician that will fit each patient into the adjustable exoskeleton system and provide customized programming to meet each user's specific needs. The training program will be initiated based upon each patient's comfort in the exoskeleton and ability to stand with assistance. Each patient will be closely monitored to assess ongoing health as well as their individual standing and walking ability. All exoskeleton sessions will be performed with a trained medical professional controlling the exoskeleton. Patient safety is the primary concern and all adverse events will be documented and addressed. This study will evaluate the ExoAtlet 2.0 exoskeleton for safety and effectiveness of providing persons with a spinal cord injury (SCI) who are non-ambulatory or have limited ambulatory function, the ability to stand up and walk in a clinical facility.

Conditions

Interventions

TypeNameDescription
DEVICEGait training using ExoAtlet exoskeletonSubjects will learn to use the ExoAtlet II exoskeleton, with the assistance of a trained medical professional, to perform functional activities (including stand-up, sit-down, stepping forward, and walking).

Timeline

Start date
2019-11-18
Primary completion
2020-01-04
Completion
2020-01-04
First posted
2020-01-02
Last updated
2023-07-27

Locations

1 site across 1 country: Russia

Source: ClinicalTrials.gov record NCT04215081. Inclusion in this directory is not an endorsement.